{
    "Trade/Device Name(s)": [
        "Nova One Blood Glucose Monitor",
        "Nova One Blood Glucose Monitoring System",
        "Nova One Blood Glucose Test Strips",
        "Nova Max Control Solutions"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K122435",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112638",
        "K080641"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "December 20, 2012",
    "Summary Letter Received Date": "December 17, 2012",
    "Submission Date": "December 12, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality Control (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Arterial whole blood",
        "Capillary whole blood (finger, forearm)"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "Syringe"
    ],
    "Instrument(s)/Platform(s)": [
        "Nova One Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric electrochemical sensor",
        "Glucose Dehydrogenase-FAD chemistry"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for Nova One Blood Glucose Monitor and Test Strips for quantitative measurement of blood glucose in venous, arterial, and capillary whole blood using coulometric electrochemical technology.",
    "Indications for Use Summary": "Quantitative measurement of glucose in venous, arterial, and fresh capillary whole blood from finger and forearm for multiple-patient use in professional healthcare settings to aid monitoring effectiveness of diabetes control program; not intended for diabetes diagnosis, screening, or neonate use.",
    "fda_folder": "Clinical Chemistry"
}